New Onset Type 1 Diabetes: Role of Exenatide

Clinical trial NCT01269034 · COMPLETED

Trial details

NCT number: NCT01269034
Sponsor: Albert Einstein College of Medicine
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2010-12-01
Primary completion: 2017-01-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.